SZ
Sarah Zohar
Inserm
Director of Research
Biography
Head of HeKA, Sarah Zohar is an expert in innovative methods for interventional and observational health data modeling including drug and Digital Medical Devices evaluation. She has made many methodological contributions for exploratory clinical trials and real-life health data analysis proposing novel methods and approaches that have been applied in cancer, rare diseases, resistance to antibiotics and pediatric clinical trials among other fields. She has collaborated with physicians in the designing, planning, conducting and analyzing clinical trials and she has developed new approaches in collaboration with international methodological experts from USA, Japan and Europe. She is a member at the French HTA for Medical Device reimbursement commission, that is, CNEDIMTS at HAS (“Haute Autorité de Santé”). She is currently participating at the French HTA, HAS, working group on “Digital medical devices for professional use”. She has participated to a workgroup for the access to innovative drugs at French HTA, this workgroup work was published in BMJ Evidence Based Medicine 2023. (http://dx.doi.org/10.1136/bmjebm-2022-112091). She is part of the European taskforce of EIT Health and the French Ministry of Solidarity and Health for “harmonization of clinical studies criteria & methodologies in Europe for the evaluation of digital medical devices. She has been invited to speak as Key note speaker or contributor at a number of international scientific meetings.
Loading